Olink's technology Proximity Extension Assay works by utilizing pairs of antibodies with DNA tags that prime polymerase chain reaction when bound to the targeted protein. Using Olink EXPLORE, next-generation sequencing capabilities is used to quantify each of 3,072 protein targets, the company said.

Tataa Biocenter will use the Olink EXPLORE for proteome analysis in the European Union-funded projects: "Identifying molecular mechanisms of pain related disorders" (PAINFACT) and "Combining optoacoustic imaging phenotypes and multiomics to advance diabetes healthcare" (OPTOMICS), the company said.